Pharmacology

In a randomized clinical trial, a team of researchers compared the use of cefepime and piperacillin-tazobactam—commonly used medications for empirical treatment of infection—to determine the risks of...

This COVID-19 roundup includes coverage on the outcomes associated with two omicron subvariant treatments, FDA’s authorization of Novavax vaccine, the NIH Treatment Guidelines Panel’s recommendation of...

In late September, the FDA approved the first biosimilar to tocilizumab to treat adult and pediatric patients with various indications of arthritis.

The FDA has approved the first biosimilar treatment for patients living with relapsing forms of multiple sclerosis.

In a placebo-controlled, randomized trial, researchers tested the efficacy of cytisinicline—a smoking cessation medication—for those who would like to quit smoking.

Following two randomized studies, the FDA has approved zuranolone for the treatment of postpartum depression in adults—the first if its kind.

This COVID-19 roundup includes coverage on the FDA-approved oral antiviral treatment for adults with mild-to-moderate COVID-19, how antidepressant medication may lower the incidence of COVID-19, a study...

The FDA has approved empagliflozin, and empagliflozin and hydrochloride to help manage type 2 diabetes in pediatric patients.

The FDA has approved a new buprenorphine treatment option for people with opioid use disorder following clinical trials that tested its safety and efficacy.

Following two studies, the FDA has approved the first cellular therapy for the treatment of type 1 diabetes in patients.